Call for Abstract
Scientific Program
5th Annual European Pharma Congress, will be organized around the theme “Conscientious Awareness of Pharmacists and Pharmaceutical Sciences”
Pharma Europe 2016 is comprised of 21 tracks and 0 sessions designed to offer comprehensive sessions that address current issues in Pharma Europe 2016.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Track 1:Pharmaceutical Marketing:
Pharmaceutical marketing called as Medico-marketing or Pharma marketing in some countries. It is the business of advertising or otherwise promoting the sale of pharmaceutical products or drugs. Emergences of new technology in recent years help in promotion.
The pharmaceutical market been increasingly more affected through laws and regulations but has shown continuous growth as the diagnosis and understanding of diseases and condition has evolved and improved. The pharmaceutical market in Denmark was valued some 2.1 billion euros. Thus, Denmark was ranked among the numerous smaller pharmaceutical markets in Europe.
- Track 1-1Pharma Market Research
- Track 1-2Global Pharma Market
- Track 1-3European Pharma Market
Track 2: Pharma Manufacturing:
The process of industrial-scale synthesis of pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be broken down into a series of unit operations such as Milling, Granulation, Coating, Tablet pressing and others .before drug can be manufactured much work goes on formulation. Drug is evaluated and later modified into required dosage form
The global manufacturing market totalled $200.6 billion in 2013 and is expected to grow to nearly $234 billion in 2014. The total market is expected to grow to $386.7 billion by the end of 2019 at compound annual growth rate (CAGR) of 10.6%.
- Track 2-1Pharma Contract Manufacturing
- Track 2-2Pharma Manufacturing
- Track 2-3Pharma Machinery
Track 3: Pharma Consulting and Services:
The Pharma consultants work with organizations of all sizes including academic institutes, start-up companies, and established organizations. The services aims to increase the patient’s knowledge of their medication and improve their adherence to the regimen.
Globally Pharma Market ranges from $870-$900 billion and in Europe $260-$280 billion from which Germany provides ready access to internationally renowned scientists, world-class research and pharmaceuticals markets. Nanotechnology
Packaging is one of the largest industry sectors in the world, worth several billions. Pharmaceutical packaging represents a meagre percentage of this colossal market. The global healthcare industry has seen a shift in paradigm and is now skewed toward effective and meaningful packaging. Packaging was considered as an afterthought which was required merely in the final stages of manufacturing for many pharmaceutical companies about a decade ago. But of late, pharmaceutical packaging has quickly become an essential part of the drug delivery system as well as a core element of the marketing mix, through which manufacturers can differentiate their products from those of their competitors. As drug manufacturers approach the 21st century, they face a number of challenges that packaging can help them meet. The demand for pharmaceutical packaging is increasing and will continue to increase as companies rely more on packaging and labelling as media to protect and promote their products, increase patient compliance, and meet new regulations.
- Track 4-1Future of Packaging Materials
- Track 4-2Regulatory Considerations-China, US, EU, Pharmacopoeia
- Track 4-3EN 16679-Anti-Counterfeiting and Tamper Evidence Techniques
- Track 4-4Packaging for Patient Compliance
- Track 4-5Packing technology for Drug Delivery Systems
- Track 4-6Serialization implementation challenges for Pharma Companies
Track 4: Pharma Companies:
Pharma Companies in Europe - Kowa Pharmaceutical, Aegerion Pharmaceuticals Ltd, Kent Pharmaceuticals, Alan Pharmaceuticals, Alliance Pharmaceutical Limited.
Pharmaceutical Companies are knowledge driven industry and is heavily dependent on Research and Development for new products and growth. However, basic research discovering of new molecules is a time consuming and expensive process and is thus, dominated by large global multinationals.
- Track 5-1Pharma Companies Europe
- Track 5-2Pharma Companies Germany
- Track 5-3Generic Pharma Companies
- Track 5-4Global Pharmaceutical Companies
- Track 6-1Drug Discovery and Design
- Track 6-2Pharmaceutics and Drug Delivery
- Track 6-3Radiopharmaceuticals
- Track 6-4Routes of administration
- Track 6-5Fundamental Drug Development and Design
- Track 6-6Nanopores
- Track 7-1Biopharmaceutics and drug disposition
- Track 7-2Pharmaceutical technology
- Track 7-3Innovations in clinical development
- Track 7-4Pharmaceutics and drug delivery
- Track 7-5Routes of administration
The method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit at all. On the other hand, the very slow progress in the efficacy of the treatment of severe diseases, has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues. From this, new ideas on controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, bio recognition, and efficacy of drugs were generated. These new strategies, often called drug delivery systems (DDS), are based on interdisciplinary approaches that combine polymer science, pharmaceutics, bio conjugate chemistry, and molecular biology.
- Track 8-1Liposomes
- Track 8-2Hydrogels
- Track 8-3Nanoparticles
- Track 8-4Gold Nanoparticles
- Track 8-5Demerits
- Track 8-6Dendrimers
- Track 8-7Drug Loaded Erythrocytes
- Track 8-8Chronotherapeutics
- Track 8-9Lontophoresis
- Track 8-10Phonophoresis
- Track 8-11Liquid Crystals
- Track 8-12Other Novel Vesicular Herbal Formulations
- Track 8-13PrPrietary Novel Drug Delivery System of Plant Actives and Extracts
Global sales of plant products was totally estimated us $60 billion in 2002 and is expected to get higher at 6.4 % average growth rate
- Track 9-1Drugs from natural sources
- Track 9-2Computational chemistry
- Track 9-3Structure aided and computer aided drug design
- Track 9-4Molecular drug design
- Track 9-5Telemedicine
- Track 10-1Phytotherapy & Complementary medicine
- Track 10-2Protein structure prediction and molecular simulation
- Track 10-3Protein structure prediction and molecular simulation
- Track 10-4Biochemistry
- Track 10-5Exploratory development
The drug market was valued at nearly $5.8 billion during 2011 and will reach nearly $5.7 billion during 2012. Total value is expected to reach nearly $5.4 billion in 2017
- Track 11-1Behavioral pharmacology
- Track 11-2Medical Pharmacology
- Track 11-3Pharmacokinetics
- Track 11-4Clinical pharmacology
- Track 11-5Endocrine pharmacology
- Track 11-6Functional modes of the brain
- Track 11-7Neuropsychology
- Track 11-8Cognitive neuroscience and neurosystems
- Track 11-9Cardiovascular Pharmacology
- Track 11-10Ethnopharmacology
Track 10: Drugs and Regulations:
Drugs & Regulations are very important in aspects of Pharmaceutical sciences where it deals with Drug safety, Cost effectiveness, Drug rediscovery, Pharmaceutical services, Role of pharmacists, Radio Pharmaceuticals and Multiple drug use etc.
- Track 12-1Clinical Pharmacy Services: patient compliance
- Track 12-2Health care management and providers
- Track 12-3Implimentation of pharmacogenetics in USA
- Track 12-4Drug safety
- Track 12-5Drug rediscovery
- Track 12-6Pharmaceutical services
- Track 12-7Role of pharmacists
- Track 12-8Halal medication
- Track 12-9Multiple drug use
- Track 12-10Online pharmacies
- Track 12-11Good governance in pharmacy
- Track 12-12Regulatory Affairs
Track 11: Hospital pharmacist:
They are experts in the field of medicines and are not only responsible for the dispensing of prescriptions but also the purchase, manufacture and quality testing of all medicines used in a hospital. Many hospital pharmacists are qualified to prescribe in their own right. Pharmacists work closely with medical and nursing staff to ensure that patients receive the best treatment, advising on the selection, dose and administration route. They also provide help and advice to patients in all aspects of their medicines.
In 2013, there were 287,420 pharmacists and 362,690 pharmacy technicians in the United States. Since 2003, the number of pharmacists in the U.S. has fluctuated year to year, but overall has increased approximately 19 %in the last decade. The number of pharmacy technicians steadily increased in the same period, adding over 151,000 workers from 2003-2013.
- Track 13-1Drug discovery and development
- Track 13-2Industrial pharmaceutics
- Track 13-3Pre-clinical studies
- Track 13-4Clinical studies
- Track 13-5Supply chain
- Track 14-1Radiopharmaceutical Usage
- Track 14-2Bio-engineering in Pharmaceutical Industry
- Track 14-3Engineering models in biomedicine
- Track 14-4Bionic human
- Track 14-5Clinical laboratory sciences
- Track 14-6Biomedical data engineering
Track 13: Industrial Pharmacy:
Industrial Pharmacy also plays a crucial role in any drug discovery. To any novel drug discovery the industrial approach is very important to get massive commercial application. Few things which have to be considered by industries to provide a safe and cost affective medicine to the patients like Supply chain, Waste management, Product management, Post- marketing surveillance, Good manufacturing practices and Marketing.
The U.S. pharmaceutical market is the world’s most important national market. Together with Canada and Mexico, it represents the largest continental pharma market worldwide. TheUnited States alone holds some 40 percent of the global pharmaceutical market. In 2014, this share was valued around 365 million U.S. dollars. Many of the global top companies are located in the United States. In 2014, six out of the top eleven companies were U.S.-based.
- Track 15-1Waste management
- Track 15-2Product management
- Track 15-3Post- marketing surveillance
- Track 15-4Good manufacturing practices
- Track 15-5Marketing
- Track 16-1FDCA
- Track 16-2NDA
- Track 16-3Adulteration
- Track 16-4Misbranding
- Track 16-5Exemption in prescription
- Track 16-6Experimental animal ethics
- Track 16-7Human trial ethics
- Track 17-1Nanobiomaterials and biopharmaceuticals
- Track 17-2Bionanotechnology and BioMEMS
- Track 17-3Pharmaceutical engineering
- Track 17-4Nanomedicines
- Track 17-5Nanotechnology in cancer research
- Track 17-6Nanotechnology in medicine and in targeted drug delivery
- Track 17-7Nanotechnology in medicine and drug delivery imaging
- Track 17-8Nanotechnology and clinical applications
- Track 17-9Nano-drugs
- Track 17-10Nano-mechanisms for molecular Systems
Pharmaceutical formulation, in pharmaceutics, is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. The word formulation is often used in a way that includes dosage form.
Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally taken drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect.
Preformulation involves the characterization of a drug's physical, chemical, and mechanical properties in order to choose what other ingredients (excipients) should be used in the preparation. In dealing with protein pre-formulation, the important aspect is to understand the solution behavior of a given protein under a variety of stress conditions such as freeze/thaw, temperature, shear stress among others to identify mechanisms of degradation and therefore its mitigation
- Track 18-1Oral drugs
- Track 18-2Parental Formulations
- Track 18-3Topical Formulations
- Track 18-4Modified release Formulations
- Track 18-5Novel Drug Formulations
- Track 18-6Oncological Formulations
The global market for Bioinformatics is expected to grow from nearly $2.3 billion in 2014 to nearly $3.4 billion in 2019, with a compound annual growth rate (CAGR) of 8.3% for the period of 2014-2019.
- Track 19-1Bioinformatics and computational biology
- Track 19-2Biochips and bioinstrumentation
- Track 19-3Bioinformatics engineering
- Track 19-4Biolanguages
- Track 19-5Biomedical science and engineering
Track 17 : Genetics, Genetic Engineering:
Genetics is the study of genes, heredity, and genetic variation in living beings. It is basically considered a field of biology, but it bisect often with many of the life sciences like Pharmaceutical Sciences. The other aspects of this are Genetic engineering, Biomedical Engineering, Genomics Proteomics, Clinical engineering, Tissue engineering, biomedical data engineering etc.
The global genetic engineering market is expected to reach $3,514.08 Million by 2019 from $1,845.25 Million in 2014, growing at a CAGR of 13.75%. Increased R&D expenditure and growth of biotechnology and pharmaceutical industries, increased funding for genomics research, and technological advancements are the primary growth drivers for this market during the forecast period (2014–2019).
- Track 20-1Genomics and proteomics in Pharmaceutical Industry
- Track 20-2Clinical engineering in Pharmaceutical Industry
- Track 20-3Tissue engineering in Pharmaceutical Industry
- Track 20-4Identification and classification of genes
Track 18: Entrepreneurs Investment Meet
Entrepreneurs Investment Meet is an effective platform where Entrepreneurs, investors, Pharma Experts meet to share their experiences, foster collaborations across industry and academia, and evaluate emerging technologies across the globe.
The meeting is the best opportunity to reach the largest assemblage of participants from the Pharma community.